European Archives - Page 187 of 1472 - European Medical Journal

Arndt Vogel, Professor and Clinician Scientist University of Toronto

Onc Now: Episode 29: Progress in Liver Cancer Research

Arndt Vogel, Professor and Clinician Scientist at the University of Toronto, shares insights on advances in hepatocellular carcinoma, the promise of immunotherapy, and emerging biomarkers shaping liver cancer treatment.

anaphylaxis

Epinephrine for Anaphylaxis Safety: Key Study Insights

Research consistently shows that epinephrine is underused, with many patients instead receiving antihistamines or steroids despite these offering only supportive relief.

Erratum: Portable Spacer Benefits Patients with Respiratory Disease

Liver Dysfunction Linked to Early Alzheimer’s Markers in Rats

Liver Dysfunction Linked to Early Alzheimer’s Markers in Rats

New research found early Alzheimer’s markers in rats with liver dysfunction, suggesting liver health may play a key role in dementia risk.

Doxycycline May Reduce Schizophrenia Risk

Antibiotic Doxycycline Cuts Schizophrenia Risk in Teens

Study reveals doxycycline may lower schizophrenia risk in adolescents, offering new hope for mental health prevention.

Three women wearing breast cancer awareness ribbons

New study charts 10 years in advanced breast cancer

Produced by the ABC Global Alliance and VML Health, the study highlights scientific progress, yet gaps in treatment options and outcomes.

Older Men’s Sperm Carry Greater Genetic Risks

Older Men’s Sperm Carry Greater Genetic Risks

A new study reveals that as men age, sperm accumulate more mutations, increasing the risk of passing on genetic and developmental disorders to their children.

Epstein–Barr Virus Found to Reprogramme Immune Cells and Trigger Lupus

A new study reveals how Epstein–Barr virus reprogrammes B cells into autoimmune drivers, uncovering a direct mechanism linking EBV infection to lupus development.

Mediterranean diet

Mediterranean Diet Found Effective for IBS Relief

Mediterranean diet eased irritable bowel syndrome symptoms more effectively than standard dietary guidance in a new UK clinical trial.

Lenacapavir and bNAbs Maintain HIV-1 Suppression

Lenacapavir and bNAbs Maintain HIV-1 Suppression

These findings highlight that lenacapavir and bNAbs can maintain high rates of virologic suppression while presenting a low risk of resistance.